Evaluating the COVID-19 responses of Belgium, Denmark, Germany, the Netherlands, Sweden and the United Kingdom, February-June 2020: A counterfactual modelling study

Pieter T. de Boer, Fuminari Miura, Giske R. Lagerweij, Jacco Wallinga
doi: https://doi.org/10.1101/2024.07.05.24309992

Article Information

doi 
https://doi.org/10.1101/2024.07.05.24309992
History 
  • July 5, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Pieter T. de Boer1,*,
  2. Fuminari Miura1,
  3. Giske R. Lagerweij1 and
  4. Jacco Wallinga1,2
  1. 1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
  2. 2Department of Biomedical Data Sciences, Leiden University Medical Center, the Netherlands
  1. ↵*Corresponding author: Pieter T. de Boer, dr., Postbus 1 (box 75), 3720 BA, Tel: +31 6 29637752, Bilthoven, the Netherlands Pieter.de.boer{at}rivm.nl
Back to top
Posted July 05, 2024.
Download PDF
Email
Evaluating the COVID-19 responses of Belgium, Denmark, Germany, the Netherlands, Sweden and the United Kingdom, February-June 2020: A counterfactual modelling study
Pieter T. de Boer, Fuminari Miura, Giske R. Lagerweij, Jacco Wallinga
medRxiv 2024.07.05.24309992; doi: https://doi.org/10.1101/2024.07.05.24309992
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area